Ian Leonard Smales

Title: Ian Leonard Smales: Innovator in Pharmaceutical Chemistry

Introduction

Ian Leonard Smales is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. His work focuses on addressing critical health issues, including abnormal cell growth and cancer treatment.

Latest Patents

Ian Leonard Smales holds a patent for a crystalline form of lorlatinib free base. This invention relates to a crystalline form of (10R)-7-amino-12-fluoro-2,10,16-trimethyl-5-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclo-tetradecine-3-carbonitrile (lorlatinib) free base, known as Form 7. The patent also encompasses pharmaceutical compositions that include Form 7 and methods for utilizing this compound in the treatment of abnormal cell growth, such as cancer, in mammals.

Career Highlights

Ian is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development aimed at creating effective treatments for various diseases. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.

Collaborations

Throughout his career, Ian has collaborated with talented professionals, including Klimentina Dimitrova Pencheva and Melissa Jane Birch. These collaborations have contributed to the advancement of innovative solutions in the pharmaceutical field.

Conclusion

Ian Leonard Smales exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions, particularly in the development of lorlatinib, highlight the importance of research in combating serious health challenges. His work continues to inspire advancements in medical treatments.